FLOXAPEN 500mg | FLUCLOXACILLIN ORIGINAL – 10 CAPS

Hepatitis and cholestatic jaundice have occasionally been reported while using FLOXAPEN in Kenya; older patients and those receiving more than 2 weeks treatment of Flucloxacillin are at greater risk. Fatalities have occurred, especially in patients with serious underlying hepatic disease. Rare reports of erythema multiforme, toxic epidermal necrolysis, and Stevens-Johnson syndrome associated with flucloxacillin have been made. Agranulocytosis and neutropenia have been associated rarely with isoxazolyl penicillins such as flucloxacillin. Phlebitis has followed intravenous infusion.